Skip to main content
Equibles

Universal- Beteiligungs- und Servicegesellschaft mbH

Position in SYRE — Spyre Therapeutics, Inc.

CIK 2057170 FRANKFURT AM MAIN, 2M
Back to SYRE Full portfolio

Position in SYRE

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$15,352,103
+$6,758,086 QoQ
Shares Held
172,923
+1.5% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#62
of 266 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Universal- Beteiligungs- und Servicegesellschaft mbH holds $748,581,038 across 107 Biotechnology names. SYRE ranks #13 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 323,752 $160,817,330
2 REGN
Regeneron Pharmaceuticals, Inc.
 100,286 $62,532,332
3 ALNY
Alnylam Pharmaceuticals, Inc.
 157,223 $47,328,839
4 JAZZ
Jazz Pharmaceuticals plc
 134,388 $32,383,476
5 INCY
Incyte Corp
 236,172 $26,772,457
6 EXEL
Exelixis, Inc.
 452,133 $24,600,556
7 IONS
Ionis Pharmaceuticals Inc
 233,499 $18,514,135
8 PRAX
Praxis Precision Medicines, Inc.
 48,118 $16,109,425

All Filings in SYRE

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,352,103 172,923
2026-03-31 $8,594,017 170,381
2025-12-31 $5,608,872 171,211
2025-09-30 $1,851,242 110,456
2025-06-30 $1,635,981 109,284
2025-03-31 $1,941,379 120,321
2024-12-31 $2,843,721 122,153